Jianye Zhang Selected Research

Jianye Zhang Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 01/2017
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 01/2017
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2005
7	Schizophrenia (Dementia Praecox) 12/2021 - 12/2015
5	Retinal Degeneration 10/2022 - 01/2015
4	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2020
4	Retinal Diseases 10/2022 - 01/2017
3	Carcinoma (Carcinomatosis) 03/2023 - 01/2017
2	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2023 - 09/2020
2	Leber Congenital Amaurosis 10/2022 - 01/2018
2	Photophobia (Light Sensitivity) 10/2022 - 01/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 03/2018
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 03/2014
2	Pain (Aches) 11/2017 - 10/2012
2	Phototoxic Dermatitis (Phototoxicity) 01/2017 - 07/2015
2	Crohn Disease (Crohn's Disease) 01/2017 - 11/2016
2	Macular Degeneration (Age-Related Maculopathy) 07/2015 - 06/2015
2	Sclerosis 12/2009 - 04/2008
1	Muscular Atrophy (Muscle Atrophy) 03/2024
1	Peripheral Nerve Injuries 03/2024
1	Stargardt Disease 12/2023
1	Cardiomyopathies (Cardiomyopathy) 12/2023
1	Myocardial Infarction 12/2023
1	Hypoalbuminemia 01/2023
1	Infections 01/2023
1	Adenocarcinoma of Lung 07/2022
1	Carcinogenesis 04/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Urogenital Neoplasms 01/2022
1	Rheumatoid Arthritis 01/2022
1	Pathologic Constriction (Stenosis) 10/2021

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2008
6	Retinaldehyde (Retinal)IBA 10/2022 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2005
4	RetinoidsIBA 10/2022 - 06/2015
4	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 12/2015
3	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
3	Aminobutyrates (Aminobutyric Acid)IBA 10/2017 - 12/2015
3	gamma-Aminobutyric Acid (GABA)IBA 10/2017 - 12/2015
2	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
2	NitrogenIBA 01/2024 - 11/2020
2	IntegrinsIBA 02/2023 - 01/2020
2	MethyltransferasesIBA 01/2022 - 01/2021
2	FibrinIBA 01/2022 - 01/2021
2	retinylamineIBA 01/2021 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 05/2008
2	Therapeutic UsesIBA 11/2020 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 07/2019
2	EnzymesIBA 07/2018 - 10/2008
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2018 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 02/2018 - 01/2018
2	Rhodopsin (Visual Purple)IBA 01/2018 - 03/2014
2	Glutamic Acid (Glutamate)FDA Link 10/2017 - 01/2016
2	OpsinsIBA 01/2017 - 03/2014
2	AndrogensIBA 12/2006 - 01/2005
1	HydrogelsIBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	Biocompatible Materials (Biomaterials)IBA 03/2024
1	gambogic acidIBA 01/2024
1	pyrimidineIBA 01/2024
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2024
1	CeramidesIBA 12/2023
1	GadoliniumIBA 12/2023
1	hydrogen sulfite (bisulfite)IBA 03/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	cinobufaginIBA 01/2023
1	GlucocorticoidsIBA 01/2023
1	FatsIBA 01/2023
1	Linezolid (Zyvox)FDA Link 01/2023
1	Vancomycin FDA LinkGeneric 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	retinol acetateIBA 10/2022
1	endostar proteinIBA 07/2022
1	RamucirumabIBA 07/2022
1	FlavonoidsIBA 07/2022
1	Bevacizumab (Avastin)FDA Link 07/2022
1	Angiogenesis InhibitorsIBA 07/2022
1	ApigeninIBA 07/2022
1	5-hydroxymethylcytosineIBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	Synthetic DrugsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	7-hydroxycoumarin (umbelliferone)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	guadecitabineIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	MagnesiumIBA 01/2022
1	A 7 (A-7)IBA 01/2022
1	ScopoletinIBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022

Therapy/Procedure

11	Therapeutics 03/2024 - 01/2005
5	Immunotherapy 03/2024 - 01/2020
3	Drug Therapy (Chemotherapy) 12/2022 - 01/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2023 - 01/2023
2	Traditional Medicine (Folk Remedies) 05/2021 - 10/2012
2	Moxibustion 01/2017 - 11/2016
1	Length of Stay 01/2023
1	Radiotherapy 12/2022